Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea · Delayed Price · Currency is KRW 3,340.00
+45.00 (1.37%)
At close: Nov 13, 2026
Seoulin Bioscience Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 83,165 | 77,091 | 75,410 | 89,569 | 104,708 | 80,539 |
Revenue Growth | 17.13% | 2.23% | -15.81% | -14.46% | 30.01% | 23.74% |
Gross Profit Gross Profit Growth | 17,753 | 17,282 | 18,961 | 19,871 | 24,292 | 21,070 |
Operating Income Operating Income Growth | 504.08 | 691.62 | 952.67 | 2,495 | 9,198 | 7,451 |
Net Income Net Income Growth | 916.61 | 731.98 | 2,914 | -117.55 | 10,159 | 15,589 |
Earnings Per Share EPS Growth | 26.97 | 55.21 | 327.12 | -13.11 | 780.07 | 1732.89 |
EPS Growth | -85.16% | -83.12% | - | - | -54.98% | 218.90% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Biotechnology Division Biotechnology Division Growth | 81,105 | 75,306 | 73,235 | 86,378 | 100,272 | 76,174 |
HealthCare Sector HealthCare Sector Growth | 2,125 | 1,859 | 2,309 | 3,262 | 4,478 | 4,477 |
Inter Segment Sales Inter Segment Sales Growth | -64.65 | -72.97 | -134.02 | -70.92 | -42.16 | -112.26 |
Total Total Growth | 83,165 | 77,091 | 75,410 | 89,569 | 104,708 | 80,539 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 30,211 | 34,716 | 23,510 | 35,414 | 55,280 | 75,332 |
Total Debt Total Debt Growth | 13,279 | 11,580 | 3,680 | 6,714 | 17,785 | 15,738 |
Net Cash (Debt) Net Cash Growth | 16,932 | 23,137 | 19,830 | 28,700 | 37,495 | 59,594 |
Net Cash Growth | -13.51% | 16.68% | -30.91% | -23.46% | -37.08% | 211.92% |
Net Cash Per Share Net Cash Per Share Growth | 1543.96 | 2400.48 | 2226.11 | 3201.94 | 3369.03 | 6625.03 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 229.38 | 4,760 | -4,611 | 930.57 | -4,356 | 8,918 |
Capital Expenditures CapEx Growth | -328.01 | -392.61 | -48.45 | -945.51 | -461.62 | -933.29 |
Free Cash Flow Free Cash Flow Growth | -98.63 | 4,367 | -4,660 | -14.95 | -4,817 | 7,984 |
Free Cash Flow Growth | - | - | - | - | - | 143.19% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 21.35% | 22.42% | 25.14% | 22.18% | 23.20% | 26.16% |
Operating Margin | 0.61% | 0.90% | 1.26% | 2.79% | 8.78% | 9.25% |
Pretax Margin | 1.19% | 1.15% | 4.71% | -2.15% | 13.40% | 25.25% |
Profit Margin | 1.10% | 0.95% | 3.86% | -0.13% | 9.70% | 19.36% |
FCF Margin | -0.12% | 5.67% | -6.18% | -0.02% | -4.60% | 9.91% |
Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 97.734 | 97.734 |
Dividend Per Share Growth | -2.27% | - |
Dividend Yield | 2.93% | 1.50% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 123.82 | 78.50 | 21.09 | - | 9.60 | 11.21 |
Forward PE | - | 19.70 | 19.70 | 19.70 | 19.70 | 19.70 |
P/FCF Ratio | - | 13.16 | - | - | - | 21.89 |
PS Ratio | 0.35 | 0.75 | 0.82 | 0.88 | 0.93 | 2.17 |